May 2026 was the most polarized month for activist short sellers this report has covered. Twenty-one campaigns produced an average impact of essentially zero, but that flat headline conceals a barbell: three targets collapsed more than 25% while four others rallied more than 29% in defiance of the research. The month rewarded firms that documented dilution mechanics and fabricated business claims, and it punished those whose targets sat in the path of speculative momentum in energy and AI names. The 62% success rate held close to recent norms, yet the spread between the best and worst outcome, from Akanda's 48.5% collapse to T1 Energy's 59.8% rally, spanned more than 108 percentage points.

The Month in Short

1. 13 of 21 targets declined following activist research, a 62% success rate, with 38% of all targets falling at least 5% in the measurement window.

2. Dispersion defined the month. The average impact was a nearly flat -0.19%, but three campaigns produced declines beyond 25% while four targets rallied more than 29% against the reports.

3. Fugazi Research's Akanda (AKAN) campaign delivered the month's deepest decline at -48.5%, driven by a thesis centered on a toxic dilution structure and a quiet pivot away from cannabis.

4. Culper Research targeted NVIDIA (NVDA), the world's largest company, alleging continued China GPU revenue via diversion networks. Shares fell 6.1%, a rare activist short result at mega cap scale.

5. Semiconductors were the month's most productive hunting ground. All three semiconductor targets declined, averaging -18.1%, while electrical equipment targets rallied an average of +44.7% against their reports.

Top Performing Shorts

The common thread among May's deepest declines is evidence of structural or mechanical problems rather than valuation arguments alone. Fugazi's Akanda thesis documented a dilution pipeline of more than 6.7 million registered conversion shares against a float of roughly 534,000, and the stock nearly halved. Night Market Research's POET campaign attacked the substance of claimed commercial partnerships at a company trading near 3,700x revenue, and Fugazi's Cue Biopharma report landed in the same window as a dilutive PIPE financing and a leadership change. Kerrisdale's Everspin call, a more traditional valuation re-rating argument on a stock that had tripled in weeks, also worked, suggesting the market remained willing to fade speculative spikes when a credible anchor was supplied.

Stock Prices That Defied the Reports

The four largest moves against reports came from targets riding speculative momentum in energy and AI. Fuzzy Panda's T1 Energy thesis, built on FEOC compliance and tax credit eligibility, was overwhelmed by strength in solar names. Manatee's detailed Amprius report on related-party sourcing and order quality met a battery sector rally, and Shortfinder's Palladyne call ran into AI robotics enthusiasm. Fugazi's MMTEC campaign explicitly described an engineered squeeze dynamic, and the stock's 42.8% rally in the measurement window arguably illustrated the mechanics the report warned about. In each case the moves reflected sector flows and float dynamics more than any specific rebuttal of the research.

Market Breakdown

The exchange split tells most of May's story in two numbers. The 14 NASDAQ-listed targets averaged a 5.3% decline, while the five NYSE names averaged a 15.8% gain, almost entirely the work of T1 Energy and Amprius. European targets continued the pattern of measured declines following research: Hunterbrook's Czechoslovak Group campaign in Amsterdam and Grizzly's Ottobock report in Germany both produced moves in the 3% to 5% range, consistent with how European markets have absorbed activist short research this year.

Ottobock (OBCK.DU) exchange and country assigned from report context; these fields were unavailable in the source data.

Industry Analysis

Semiconductors stood out as the only multi-report sector where every campaign succeeded. Night Market's POET, Kerrisdale's Everspin, and Culper's NVIDIA all declined, an unusual sweep given how strongly the broader chip complex has traded. Biotechnology delivered a negative average on the strength of Cue Biopharma's 32.6% drop, while the two electrical equipment campaigns ran into the month's heaviest momentum. The software pairing of MMTEC and Palladyne was the other pocket of resistance, with both targets rallying 30% or more. Late in the month, Sunlight Partners challenged Babcock & Wilcox's pivot to gas steam plants for AI power demand, arguing the core business is worth a fraction of the share price, and the stock declined 4.8% into month end.

Market Cap Analysis

May inverted the usual size relationship. The two largest targets in the dataset, Czechoslovak Group and NVIDIA, both declined, while the mid cap segment posted a positive average dragged up by Amprius despite successful campaigns against York Space Systems and Babcock & Wilcox. Small caps, which made up two-thirds of all campaigns, were nearly flat in aggregate but contained the full range of outcomes, from Akanda's collapse to T1 Energy's rally. Ottobock is excluded from this segmentation as market cap data was unavailable in the source export.

Firm Performance Rankings

Fourteen firms published in May, the broadest field of the year so far. Shortfinder was the most prolific with four reports, though only Tonix declined in the measurement window. Fugazi Research was the only multi-report firm with a meaningfully negative average, landing two of the month's three deepest declines. It is worth noting that the bottom of this table reflects sector momentum more than research quality: both Fuzzy Panda's T1 Energy report and Manatee's Amprius report presented detailed primary-source work that the market has so far chosen to look past.

Notable Campaigns

Strategic Insights

Short King of the Month

Short King of the Month: May 2026

Night Market Research

Night Market Research takes the May crown with the strongest firm performance of the month, a 32.9% decline in POET Technologies on its only campaign. The report attacked the substance of POET's claimed commercial partnerships at a company trading near 3,700x revenue, and the market responded decisively. Crucially, POET was a $1.4 billion NASDAQ name with deep liquidity, fully accessible to retail short sellers at publication, making this the most actionable result of the month. The win ends Fugazi Research's six-month run as Short King.

Stock Impact -32.9%

Target Ticker POET

May Success Rate 100%

Honorable mention: Fugazi Research, which landed two of the month's three deepest declines (AKAN -48.5%, CUE -32.6%) across three reports, a volume-weighted performance no other firm matched in May.

Bottom Line

May 2026 will not be remembered for its averages. A nearly flat -0.19% aggregate impact and a 62% success rate look unremarkable next to recent months, but underneath sat the widest dispersion this report has tracked, with outcomes spanning more than 108 percentage points between Akanda's collapse and T1 Energy's rally. The month drew a clear line between theses anchored in observable mechanics, such as dilution structures, financing pressure, and disputed partnerships, and theses that required the market to reprice future expectations against a backdrop of aggressive sector momentum.

The breadth of the field is its own signal. Fourteen firms published in May, including Culper Research's unprecedented move against NVIDIA, the largest company ever targeted by an activist short report in this dataset. That campaign's 6.1% result, modest in percentage terms, represents hundreds of billions of dollars in market value and suggests activist research can still move even the most crowded and well-defended names when the allegations are specific enough.

For traders, the lesson of May is about selection rather than conviction. The research that worked tended to give the market something it could verify quickly, and the research that did not often ran into flows no thesis could overcome in a three-week window. Several of the month's defied reports raise questions that remain open well past our measurement period, and we will continue tracking those campaigns in future editions.

The information provided on Activ8Insights.com, including all articles, reports, commentary, and associated content, is intended solely for informational and educational purposes. It does not constitute investment advice, an offer, or a recommendation to buy or sell any securities. All views and opinions presented aim to promote transparency and critical dialogue around activist investing, particularly short activism, and should not be interpreted as personalized financial advice. Investors are solely responsible for their own due diligence and investment decisions, based on publicly available information and their individual financial circumstances. Contributors to or affiliates of Activ8Insights may hold long or short positions in the securities mentioned. These positions may change at any time without notice, and there is no obligation to disclose such changes after publication. Any market data listed is data at the most recent market close. Market data may be delayed or changed after publication on Activ8Insights.com. Stock impact figures reflect price movement from report publication through month end and may differ from peak drawdowns or subsequent performance.